McCormick is being recast from an independent flavor specialist into the surviving legal shell of a Reverse Morris Trust with Unilever Foods. That structure, a tax-efficient spin-and-merge, leaves current McCormick holders with 35% of a much larger flavor company. Combined fiscal twenty twenty-five revenue is framed at about $20 billion. The cash consideration of $15.7 billion is large enough to push combined net leverage toward four times earnings before interest, taxes, depreciation, and amortization at close. The equity now trades as a merger stub rather than as a defensive spice franchise.
The second-quarter print still belongs to the standalone company, and it is a mixed one. Reported sales jumped because McCormick de Mexico is now consolidated after the January purchase of another quarter of the joint venture, not because the core spice aisle suddenly accelerated. Organic growth was only 1.7%, and Americas Consumer volume declined even as list prices rose. Gross margin looked stronger than the underlying business, because a $28 million refund of International Emergency Economic Powers Act tariffs accounted for more than half of the expansion. Adjusted earnings of $0.80 beat the year-ago print, but GAAP earnings fell as merger-related special charges and higher interest absorbed the operating gain.
The investment debate is whether the current price already embeds the dilution, the leverage, and the integration risk, or whether it still treats McCormick as a premium compounder that happens to have a deal overlay. Midpoint guided adjusted earnings sit near $3.09, and the shares change hands around fifteen times that figure, a premium to slower packaged-food peers even after a sharp drawdown from last year's high. The next several quarters resolve three variables: whether Consumer volume in the Americas stabilizes, whether Mexico's accretion holds after the tariff refund fades, and whether regulators and McCormick shareholders actually deliver a mid-twenty twenty-seven close.